17.beta.-(cyclopropyloxy)androst-5-en-3.beta.-ol and related compounds useful as C.sub.17-20 lyase inhibitors
US4891367A · kind A · utility
10Cited by
10References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 22, 1987 |
| Grant date | Jan 2, 1990 |
| Priority date | — |
| Expiry date | Apr 22, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention is directed to 17.beta.-(cyclopropyloxy)androst-5-en-3.beta.-ol and related compounds and also to a method for using such compounds in the treatment of androgen-dependent disorders. The ethers are prepared by using the Simmons-Smith reaction and an appropriate vinyl ether.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.